Akoya Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Akoya Biosciences

14/03/2022 21:46

* Akoya Biosciences Inc  AKYA.OQ  reported a quarterly
adjusted
loss of 47 cents​​ per share for the quarter ended in December.
The mean expectation of four analysts for the quarter was for a
loss of 31 cents per share.
    * Revenue was $16.16 million​;  analysts expected $16.05
million. 
    * Akoya Biosciences Inc's reported EPS for the quarter was a
loss
of 47 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Akoya Biosciences Inc shares had fallen by 35.7% this
quarter.
    * The company reported a quarterly loss of $17.67 million.
    * Wall Street's median 12-month price target for Akoya
Biosciences
Inc is $24.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 14 at 09:46 p.m.  ​All
figures in US dollars unless otherwise stated